What to Include in a Service Agreement for a UK Clinical Trial Services Business

If you provide clinical trial services in the UK, your service agreement does far more than set out fees and timelines. It is where you allocate regulatory responsibilities, define exactly what is being delivered, and protect your business if a sponsor, site, CRO or subcontractor expects more than you agreed to provide. Founders often get caught by three mistakes: accepting another party's standard terms without checking who owns the data and work product, using vague scopes of work that blur operational tasks with regulated responsibilities, and signing contracts that push unlimited liability onto the provider.

That matters because clinical trial work sits close to patient safety, personal data, protocol compliance and strict sponsor expectations. A badly drafted contract can leave you exposed to claims for delays, protocol deviations, confidentiality breaches or failures that were never really within your control.

This guide explains the main service agreement clauses for clinical trial service provider businesses in the UK, what those clauses should cover in practice, the legal issues to check before you sign, and the mistakes that most often cause trouble later.

Overview

A good clinical trial services agreement should clearly separate commercial promises from regulated responsibilities. It should say what you will do, what you will not do, what the client must provide, and what happens if the study changes, pauses or ends early.

The strongest agreements usually deal with scope, compliance, data handling, liability and exit in specific terms rather than generic boilerplate.

• define the services, deliverables, milestones and assumptions in detail
• state which party is responsible for protocol design, regulatory submissions, site management, safety reporting and quality oversight
• set out change control, delays, dependencies and the effect of sponsor instructions
• cover confidential information, study data, intellectual property and publication rights
• address UK GDPR obligations and who acts as controller, joint controller or processor
• limit liability sensibly and carve out only the risks that genuinely need special treatment
• include subcontracting rules, audit rights, record retention and inspection cooperation
• spell out payment terms, pass-through costs, termination rights and what happens on handover

What Service Agreements Cover

A clinical trial services agreement should say, in plain terms, who is doing what, to what standard, and at whose risk. The more specialised the service, the less safe it is to rely on broad wording.

Scope of services

Your scope clause is the centre of the contract. If it is too short or too general, arguments start as soon as timelines slip or a sponsor asks for extra work.

For a UK clinical trial services business, the scope should separate core contracted services from optional or out-of-scope work. That is especially important where you provide a mix of project management, vendor management, site support, monitoring, data services, pharmacovigilance support, logistics or regulatory coordination.

A well-drafted schedule will usually include:

• the exact services to be performed
• the study phase, territories, sites or patient groups covered
• deliverables and reporting requirements
• service levels, response times or milestones, where appropriate
• client dependencies, such as protocol approval, database access, training, study materials or site cooperation
• assumptions and exclusions
• which tasks require written change requests before they are added

This is where founders often get caught. A client may treat attendance at extra sponsor calls, rework after protocol amendments, repeated document revisions or urgent weekend support as included. If the contract does not draw a line, you may end up absorbing the cost.

Regulatory and quality responsibilities

The agreement should allocate regulatory responsibilities with precision, not with general statements about compliance. In the clinical trials sector, broad wording can accidentally shift legal responsibility for sponsor decisions onto a service provider.

Your contract should identify which party is responsible for matters such as:

• trial protocol development and amendment approval
• ethics and regulatory submissions
• investigator site selection and oversight
• safety reporting and escalation
• serious breach assessment and notification
• investigational product handling, where relevant
• quality management systems and standard operating procedures
• training records and staff qualifications

If you are not acting as the sponsor, the contract should avoid language that implies you are. If you are only providing support services, say so expressly. If you are following sponsor instructions, the agreement should also state how conflicting instructions, urgent deviations, or concerns about compliance are escalated and documented.

Timelines, milestones and delays

Dates in a clinical trial contract should reflect real dependencies. A provider should not promise fixed turnaround times where key inputs sit with the client, trial sites, ethics bodies or third party vendors.

Good clauses tie milestones to trigger events and include relief where delays arise from factors outside your reasonable control. For example, you may need the right to extend timelines where the client changes the protocol, delays approvals, provides incomplete information, or instructs work outside the agreed scope.

You should also deal with paused studies, recruitment delays and early termination. In practice, these situations are common, and they can have major staffing and cost implications.

Fees and payment mechanics

Fees need more than a headline number. The contract should say how you charge, when invoices are issued, what expenses are recoverable and what happens if the study changes.

Many clinical trial service providers use a mix of fee structures, such as:

• fixed fees for defined deliverables
• time and materials for variable support
• monthly retainers for ongoing project management
• pass-through costs for travel, couriers, specialist vendors or database licences
• set-up, close-out or cancellation charges

If the study is delayed or suspended, you may still incur staff costs, system costs and third party commitments. Your agreement should allow for re-budgeting, hold fees, or payment for work already booked and performed.

Data protection, confidentiality and study data

Clinical trial contracts often combine confidential business information with sensitive personal data. The agreement needs separate clauses for confidentiality and data protection because they do different jobs.

Confidentiality clauses should cover protocols, study materials, pricing, commercial strategy, technical processes and any non-public information shared during the project. They should also say when disclosure is allowed, such as to regulators, auditors, professional advisers or approved subcontractors under equivalent duties.

Data protection clauses should deal with the actual role each party plays under UK data protection law. Depending on the service model, you may act as a processor, an independent controller, or in some cases part of a joint controller arrangement. The contract should address:

• the data roles of each party
• permitted processing purposes
• security measures
• international transfers, if any
• sub-processor approval
• incident reporting and cooperation
• data retention and deletion rules
• support with data subject requests, where relevant

If the agreement simply labels one party as processor without matching the reality of the work, that can create compliance problems later.

Intellectual property and ownership

Your contract should distinguish between background intellectual property and project outputs. Otherwise, a client may assume it owns your templates, tools, methods and know-how just because you used them during the engagement.

Common ownership issues include:

• pre-existing documents, software, templates and methodologies
• study-specific reports, trackers and deliverables
• database structures and system outputs
• improvements to your internal processes
• licences needed for the client to use the deliverables

If you provide bespoke materials, think carefully about whether ownership should transfer, or whether the client only needs a licence to use them for the particular study.

Liability, indemnities and insurance

The main risk in many provider contracts is not the scope of work, it is the liability clause buried near the end. Some customers try to impose uncapped liability for delay, data issues, protocol non-compliance and third party losses, even where the provider only had a limited operational role.

A sensible agreement should include:

• a cap on liability, often linked to fees or insurance cover
• exclusion of indirect or consequential losses where appropriate
• carefully limited indemnities
• carve-outs only for specific serious matters, such as fraud or liabilities that cannot legally be limited
• a duty on the client to mitigate loss

Before you accept the provider's standard terms, check whether warranties or indemnities effectively make you responsible for the study as a whole. That is a common contract review issue in this sector.

Termination and exit support

The agreement should explain how the relationship ends and what happens next. Clinical trial projects often stop unexpectedly because of recruitment issues, budget changes, sponsor decisions or regulatory concerns.

Your termination clauses should cover:

• termination for material breach
• termination for convenience, if commercially appropriate
• the notice period
• payment for work done up to termination
• recovery of non-cancellable third party costs
• return or transfer of data, records and study materials
• reasonable exit assistance at agreed rates

If handover is required, say how long support will continue and whether it is chargeable. Exit work can be substantial, especially if another provider is stepping in mid-study.

Legal Issues To Check Before You Sign

Before you sign a contract for clinical trial services, check whether the legal wording matches the operational reality of the project. The biggest problems arise when standard legal text ignores how the study will actually run.

Who is really responsible for what

Read the contract against the protocol, proposal, budget and statement of work together. A clean legal clause is not enough if the commercial documents promise more than the main body of the agreement allows for.

You should check for mismatches such as:

• the proposal offering strategic oversight, while the contract says you only provide administrative support
• the scope excluding safety reporting, while the work order includes safety deliverables
• the contract stating that timelines are fixed, while the project plan depends on client sign-off and site responses

If those documents do not align, the client will usually rely on the version that suits it when a dispute starts.

Whether the data clauses fit the arrangement

Clinical trial services often involve sensitive health information or coded participant data. Before you sign, be clear about whether you will access personal data directly, host it, analyse it, or simply handle study administration without identifiable records.

The contract should also fit your actual systems and suppliers. If you use third party platforms, cloud tools, specialist vendors or overseas support teams, the data protection and subcontracting clauses must reflect that. Otherwise, you may promise controls you cannot deliver in practice.

Whether audit and inspection rights are workable

Sponsors and larger CROs often want broad audit rights. Some oversight is expected in this sector, but the clause still needs boundaries.

Check:

• how much notice must be given
• how often audits can occur
• whether they can access competitor-sensitive material
• whether they can copy documents freely
• whether on-site audits must follow security and confidentiality rules
• how regulator inspections differ from customer audits

You should cooperate with legitimate compliance reviews, but you do not need to accept unlimited operational disruption.

Whether you can actually meet the warranties

Warranty clauses often look harmless because they are written in broad business language. In practice, they can create strict promises that are hard to control.

Be cautious if you are asked to warrant that:

• services will be uninterrupted or error-free
• all work will fully comply with every applicable law in every context
• deliverables will be fit for a particular purpose not defined by you
• no third party rights will ever be infringed

Most providers should instead promise that services will be performed with reasonable skill and care, in line with applicable law and agreed procedures.

What happens if things go wrong

Your contract should have a practical process for errors, non-conformances and disputes. That includes notice periods, cure rights, escalation contacts and the consequences of a breach.

Without those mechanisms, relatively small issues can quickly become invoice disputes or termination threats. In a regulated setting, you also need room to escalate genuine compliance concerns without breaching the agreement.

Common Service Agreement Mistakes

Most service agreement problems in the clinical trials sector are caused by vague drafting, copied clauses and unrealistic assumptions. The contract often looks polished, but it does not reflect how the parties will actually work together.

Using generic consultancy terms

A standard consultancy agreement is rarely enough for a clinical trial service provider. It may miss regulatory allocation, inspection support, data role wording and study-specific dependencies.

This is where founders often rely on a verbal promise that "we'll sort it out operationally". If the agreement is generic, operational goodwill usually disappears when timelines slip or a study is paused.

Leaving the scope in the proposal only

If the legal agreement says little more than "services as agreed from time to time", you are exposed. A proposal may help, but only if it is clearly incorporated and takes priority where needed.

Before you sign, make sure the schedules are complete and signed, not still marked draft. Small omissions in the scope can lead to large unpaid workstreams.

Accepting unlimited or badly structured liability

Some providers focus heavily on winning the work and leave liability negotiations until the end. That is risky.

An uncapped liability clause can expose a small or growing business to losses far beyond the value of the project. The same applies to indemnities drafted so widely that you are effectively insuring the client's whole study.

Ignoring subcontracting and supplier flow-downs

If you use freelancers, specialist consultants, laboratories, software providers or overseas affiliates, your customer contract should line up with your supplier contracts. Otherwise, you may owe obligations to the client that your own suppliers are not bound to support.

You should check for:

• matching confidentiality duties
• matching data protection terms
• clear quality and record-keeping obligations
• rights to step in, replace or require cooperation on exit

If the flow-down is missing, your business carries the gap.

Overlooking change control

Clinical trials change. Protocol amendments, recruitment issues, extra reports and sponsor requests are part of the commercial reality.

If the agreement does not include a clear written variation process, tied to budget and delivery impact, extra work can pile up before anyone discusses fees or timelines.

Forgetting the end of the project

Founders often negotiate the start of the relationship and barely address the end. That is a mistake in trial services, where records, handover and close-out tasks can continue after active work stops.

You should know what must be returned, retained, transferred or deleted, who pays for exit support, and when your responsibilities finally end.

FAQs

Should a clinical trial service provider use the client's standard agreement?

Sometimes, but only after careful review. Client templates often favour the sponsor or CRO and may assign broad liability, strict warranties or unclear data obligations to the provider.

Who should own study data under the contract?

That depends on the service model, but ownership and use rights should be stated clearly. Even where the client owns study data, the provider usually needs rights to use its own tools, templates, know-how and de-identified service records for internal purposes where appropriate.

Do UK data protection clauses need special treatment in clinical trial contracts?

Yes. Clinical trial work can involve sensitive personal data, so the contract should accurately describe each party's role, security duties, subcontractor use, incident reporting and any international transfers.

Can a service provider limit its liability in a UK clinical trial agreement?

Usually, yes, subject to legal limits and the bargaining position of the parties. Liability caps, excluded losses and carefully drafted indemnities are common and often commercially sensible.

What documents should sit alongside the main service agreement?

Most arrangements also need schedules or related documents covering the statement of work, budget, data processing terms, service levels, project assumptions, and where relevant, quality or audit requirements.

Key Takeaways

• Service agreement clauses for clinical trial service provider businesses should clearly define scope, deliverables, assumptions and exclusions.
• The agreement should allocate regulatory, quality and operational responsibilities precisely, especially where sponsor and provider roles overlap.
• Data protection, confidentiality, intellectual property and audit clauses need to reflect how the project actually works, not just generic template wording.
• Liability caps, sensible indemnities, payment mechanics, change control and exit terms are often the clauses that matter most when a project goes wrong.
• Before you sign, compare the legal agreement with the proposal, statement of work, protocol and supplier arrangements so the documents do not contradict each other.
• If you are reviewing or negotiating service agreement clauses for clinical trial service provider and want help with scope of services, data protection terms, liability caps, and termination provisions, you can reach us on 08081347754 or team@sprintlaw.co.uk for a free, no-obligations chat.